首页> 外文期刊>The economist >Patient capital
【24h】

Patient capital

机译:病人资本

获取原文
获取原文并翻译 | 示例
           

摘要

Investors seeking opportunities in developing countries count a large healthy population as a plus. If they specialise in testing drugs and other medical therapies, the lure may be a lot of the not-so-healthy. India has such people in industrial quantities, and contract-research organisations (cros), which undertake clinical trials and other services for pharmaceutical companies, are beginning to notice. Their activities are one of the odder ways in which India is making more of a mark in services than it ever has in the export of manufactured goods.
机译:在发展中国家寻求机会的投资者将大量的健康人口视为优势。如果他们专门研究药物和其他医学疗法,那么诱饵可能不是那么健康。印度拥有大量的工业人才,并且为制药公司提供临床试验和其他服务的合同研究组织(cros)开始受到关注。他们的活动是印度在服务业中比在制成品出口中获得更多成就的怪异方式之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号